Genetic effects of adiponectin on blood lipids and blood pressure.

ABSTRACT

OBJECTIVE: Results from the published studies on the association of adiponectin gene (ADIPOQ) polymorphisms with blood lipids and blood pressure are conflicting. We investigated the association of three ADIPOQ polymorphisms, +45 T > G (rs2241766), +276 G > T (rs1501299) and -11377 C > G (rs266729), with these traits in this meta-analysis. RESEARCH DESIGN AND METHODS: We included 35 studies in this meta-analysis. Dominant models were used for this meta-analysis. RESULTS: We did not detect a significant association of the -11377 C > G polymorphism with blood lipids or blood pressure (P > 0·05). The association of the +45 T > G polymorphism with blood lipids and blood pressure was, similarly, not significant (P > 0·05). The meta-analysis suggested a significant overall association of the +276 G > T polymorphism with lower levels of total cholesterol weighted mean difference (WMD) = -0·10, 95% confidence interval (CI, -0·17, -0·03), P = 0·005, P(heterogeneity) = 0·04. This association was marginally significant in East Asians and East Asians with type 2 diabetes WMD = -0·10, 95% CI (-0·20, 0·00), P = 0·05, P(heterogeneity) = 0·002, and WMD = -0·09, 95% CI (-0·18, -0·00), P = 0·05, P(heterogeneity) = 0·80, respectively. After exclusion of a study that was the source of heterogeneity, the association was significant in overall populations and marginally significant in East Asians WMD= -0·06, 95% CI (-0·11, -0·01), P = 0·01, P(heterogeneity) = 0·98, and WMD = -0·06, 95% CI (-0·12, 0·00), P = 0·07, P(heterogeneity) = 0·83, respectively. However, none of these associations were significant after Bonferroni correction (significant threshold P < 0·003). CONCLUSIONS: Our meta-analysis does not suggest any association of the three ADIPOQ polymorphisms with blood lipids and blood pressure.